Publication Date: Oct 3 2023
Author: Ruey-Shyang Hseu, Michael Lee
Publisher: Wu Ting Yao Studio, Taipei, Taiwan
Language: English File size: 28950 KB
ISBN / 978-986-933-673-4 (EPUB)
Exclusive Online Sales: Kindle Store at Amazon.com
About this Book: GMI is an anti-cancer component from Ganoderma (Lingzhi) that has achieved a delicate balance between 'safety,' 'effectiveness,' and 'scalable mass production.' The authors' aim is to introduce GMI to a wider international audience, emphasize its transformative potential to turn cancer from a fatal disease into a manageable condition, and facilitate its utilization.
The effective anti-cancer compounds claimed in the laboratory are as rare as hen's teeth when it comes to application in the human body, primarily due to the challenge of achieving a balance between "safety," "effectiveness," and "scalable mass production."
However, a significant breakthrough has been achieved with GMI, an immunomodulatory protein derived from a specific type of Ganoderma (Lingzhi) fungus, Ganoderma microsporum.
Especially for elderly and debilitated patients with advanced metastatic cancer, who were initially given only a few months to live, the administration of GMI treatment resulted in an extension of their lifespans and the restoration of their ability to walk with ease. These remarkable outcomes have inspired the authors to share GMI with the world.
Starting from the discovery of Ganoderma microsporum to the present day, with the long-term dedication of numerous research and development personnel, the authors' team has successfully formulated a variety of functional products harnessing GMI.
Among these, the food-grade GMI has been launched in the United States, and users from all around the world have witnessed the miraculous effects of this sublingual tablet, which is as thin as a cicada's wing. Whether it's repairing oral ulcers, reducing inflammatory reactions, alleviating the side effects of targeted drugs, or assisting in anti-cancer treatment, the results are genuinely remarkable.
The Traditional Chinese version of this book, titled "GMI生醫蛋白質，抗癌新藍海," was originally introduced in June 2018. This edition, supported by scientific data and clinical evidence, effectively showcased the remarkable achievements of GMI in the battle against cancer. GMI's groundbreaking work, which has transformed cancer from a fatal disease into a manageable condition, continues to attract significant attention within the Chinese-speaking community.
Now, the authors have compiled the contents of the Traditional Chinese version into this English edition. Their aspiration is to introduce GMI, the result of merging Eastern traditional medical wisdom with Western cutting-edge biotechnology, to a broader international audience, highlight its contributions to human health, and make it accessible for Western audiences to utilize.
“These two scientists are pursuing excellent scientific research achievements and striving to seek continuous breakthroughs in disease treatment to benefit the public. I realize that they have professional integrity. In the world, there are many elites who pursue fame and success, but these two individuals are conscientious and dedicated individuals who do not forget their social responsibility. Therefore, it is with peace of mind that I share this book and information about the authors with society.”
—Tang Fe, former Premier of Taiwan
“There is no best medical treatment, only the most suitable one. To cure patients without any side effects is the best result for both doctors and patients. Perhaps the integration of cross-medical models without egocentrism is the answer to creating miracles in healthcare. We can only say that so far, there is no panacea to solve the bane of doctors in this world. However, GMI has provided a significant degree of inspiration. Although there are still many unknown mechanisms to be clarified regarding its application in the human body, the evidence of its effectiveness and harmlessness has given GMI a promising future.”
—Michael Lee, Oncologist and author of the book
“Ganoderma microsporum immunomodulatory protein (GMI) is the first Ganoderma protein to be independently mass-produced on a large scale. Its protein structure has been made public, and research utilizing GMI has resulted in over 25 published journal articles to date. Beyond its tumor-fighting capabilities, GMI has been found to possess functions, such as anti-inflammation, antioxidation, immune regulation, promotion of nerve cell growth, stimulation of the division of myoblast cells, induction of stem cell growth and differentiation, inhibition of cellular invasion by SARS-CoV-2 (Covid-19), preventing cytokine storms, and so on. It stands as one of the most remarkable biopharmaceutical proteins of this century.”
—Ruey-Shyang Hseu, Professor and author of the book
Michael Lee is a doctor of regenerative medicine and a pioneer in international stem cell therapy. He excels at integrating the principles of both traditional Chinese and Western medicine, breaking through conventional boundaries to prioritize saving lives.
Ruey-Shyang Hseu is a Professor at the Department of Biochemical Science and Technology, Institute of Microbiology and Biochemistry, College of Life Science, National Taiwan University. He has been researching Ganoderma since the 1980s. His ultimate goal is to make a specific active component within Ganoderma widely accessible to everyone.
Prologue To the English Edition
Foreword by Tang Fei: Beyond Excellence with Conscience
Preface by Ruey-Shyang Hseu: The Secret One Dare Not Keep
Preface by Michael Lee: There is No Best Medical Treatment, Only the Most Suitable
Chapter 1: Discovery of GMI
Chapter 2: Structure of GMI
Chapter 3: Production of GMI
Chapter 4: Safety of GMI
Chapter 5: Anti-Cancer Effects of GMI
Chapter 6: Anti-Cancer Mechanisms of GMI
Chapter 7: Clinical Applications of GMI in Cancer Treatment
7.1 Overall Effectiveness of the Clinical Application of GMI against Cancer
7.2 After Three Consecutive Injections of GMI, Four Tumor Markers Returned to Normal
7.3 After Two Years of GMI Treatment, Tumors Spread Throughout the Body were Reduced to Just One
7.4 After 18 Months of GMI Treatment, Five Tumors were Reduced to Just One
7.5 GMI as a Cancer Adjunct Therapy for Enhanced Effectiveness, Reduced Toxicity, and Stronger Foundations
Chapter 8: Sharing a Story of GMI Curing a Doberman's Osteosarcoma
Chapter 9: GMI's Vision and Future Prospects
Epilogue
Acknowledgments
About the Authors
About Book Series "Ganoderma 4.0"
Publication Date: Oct 3 2023Author: Ruey-Shyang Hseu, Michael Lee Publisher: Wu Ting Yao Studio, Taipei,...
COPYRIGHTS © Ganodermanews SINCE By 2015 ALL RIGHT RESERVED.
靈芝新聞網 版權所有 | 本網站內容作者享有其著作權，禁止侵害，違者必究
Powered by
ganodermanews.com
最新期／2023年秋季號